A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats
Keval Raval, Pravin Tirgar
Topics & Concepts
StreptozotocinInternal medicineGlibenclamideEndocrinologyNicotinamideMedicineDiabetes mellitusHemoglobinInsulinVery low-density lipoproteinTriglycerideType 2 diabetesCholesterolChemistryLipoproteinBiochemistryEnzymeNatural Antidiabetic Agents StudiesPharmacology and Nanomedicine ResearchPeroxisome Proliferator-Activated Receptors